NCT04155047View on ClinicalTrials.gov

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
COMBINATION_PRODUCT

Glyocopyrrolate Inhalation Solution administered by Magnair

glycopyrrolate Inhalation Solution 25mcg, single dose

DRUG

Placebo administered by Magnair

Placebo Inhalation Solution

Trial Locations (1)

63301

Midwest Chest Consultants, Saint Charles

All Listed Sponsors
lead

Sunovion Respiratory Development Inc.

INDUSTRY

NCT04155047 - A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease. | Biotech Hunter | Biotech Hunter